A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

TORONTO, ON — Two commonly used drugs used in the treatment of chronic obstructive pulmonary disease (COPD) are associated with an increased risk of cardiovascular events, a new review concludes [1].

Please provide your email address to receive an email when new articles are posted on . Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or ...

A new study reveals several new gene variants that are associated with how people living with chronic obstructive pulmonary disease respond to inhaled bronchodilators. A new study from Brigham and ...

Identifying DNA variants associated with bronchodilator responsiveness may reveal genetic pathways associated with the pathogenesis of chronic obstructive pulmonary disease and may identify novel ...

Among patients with asthma-like symptoms in primary care, testing using home spirometry may be useful for the diagnosis of ...

The results show the importance of diagnosing lung conditions through spirometry as well the necessity for more effective therapies for patients without COPD. Dual bronchodilators, often prescribed ...

—Long-acting bronchodilators are recommended for initial maintenance of COPD. A new study compares the cardiovascular safety of 2 common treatment options. Reviewed by Ware Kuschner, MD, Professor of ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

Medically reviewed by Daniel More, MD Key Takeaways Asthma action plans help maintain good asthma control by outlining ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...